Our webinars allow users to learn from experts and earn continuing education credits on industry topics, progress in research, services available, and more.
Children efficiently develop their visual systems through learning from their environment. How this development unfolds in noisy real-world data streams remains largely unknown. Deep neural...
Neural networks are a powerful tool for modeling neural activity in the brain. In this talk, I will discuss how these models have helped in my own research and highlight recent work building...
Alzheimer’s and Parkinson’s diseases (AD, PD) are the two most common neurodegenerative disorders. Both diseases are characterized by abnormal aggregates in the brain, which incl...
Some of the earliest symptoms of Alzheimer’s disease (AD) are loss of orientation, wandering and misplacing items. One of the first regions vulnerable to AD pathology is the entorhinal...
Explainable AI (XAI) aims at helping you understand and interpret predictions made by AI techniques and tools. Recently, there has been a growing interest in XAI as many users want explanati...
In this talk, I will discuss the development of interpretable machine learning models to test scientific hypotheses, with a specific focus on spinal motor control. Voluntary movement require...
Date: March 07, 2023 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET) The ability to synthesize and sequence vast numbers of DNA constructs is a cornerstone of modern high-throughput biologic...
Date: March 07, 2023 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) As most labs have moved away from paper record-keeping, electronic lab notebooks (ELNs) have become the de facto solution...
Date: March 01, 2023 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) Characterizing metastasis remains key for understanding and eradicating cancer. The study of circulating tumor cells (CTC...
Date: March 01, 2023 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) Eppendorf is launching the Bioprocess Autosampler! This new addition to our product offering helps you gain more data wit...
Date: March 01, 2023 Time: 7:00am (PST), 10:00am (EST), 4:00pm (CET) Determining the three-dimensional structure of membrane proteins has historically been a huge challenge for scientists du...
Date: February 28, 2023 Time: 11:00am (PST), 2:00pm (EST), 8:00pm (CET) Traditional methods of infection prevention to detect healthcare-associated outbreaks have remained unchanged for many...
Date: February 28, 2023 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) Prenatal infections can increase the risk of serious health complications including miscarriage, organ damage, birth...
Date: February 23, 2023 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) The RNAscope in situ hybridization (ISH) technology is a powerful method for detecting gene expression with spatial an...
Have you ever tried to access the genomic profiles of cell lines before using them in your preclinical experiments just to come up empty-handed? Maybe you’ve scoured public databases f...
Immunogens with native conformation and a high-throughput IgG cloning platform are two of the most important key components for high quality lead antibody molecules discovery. DIMABIO’...
Heparin-Induced Thrombocytopenia (HIT) is a life-threatening complication following heparin exposure. This webinar presentation will discuss the pathogenesis, incidence, clinical...
Date: February 22, 2023 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET) Circular plasmid DNA has traditionally been used as a stable and efficient vector for gene expression and HDR-mediated...
If you use a pipette on a daily basis, then this webinar is for you. Pipettes are used to prepare samples, blanks, and standards for a range of analytical experiments. This is why the wrong...
In general, once a receptor drug target has been validated for the treatment of a particular condition, either a high throughput screen is carried out to identify potential hits, or existing...
Antibody-based therapeutics are helping patients across a wide range of disease areas, from cancer, such as Rituximab treatment of CD20-positive non-Hodgkin's lymphomas, to infectious di...
Novel immunotherapy has revolutionized the landscape of cancer therapy in multiple tumor types since Ipilimumab, the first ICB agent, was approved for the treatment of metastatic melanoma is...
Novel annotated Patient-Derived tumor Xenografts (PDX) propagated in immunodeficient mice and Organoids (PDO) in Matrigel have become essential models to study inter- and intra-tumor heterog...
Advances in tissue-based technologies over the past few years have created opportunities to identify patterns that can be used as biomarkers and prognostic indicators for different disease s...
In this project, we optimized a high-throughput fluorescent-based assay to assess transporter activity by measuring uptake of the substrate, ASP+ 4-(4-(dimethylamino)styryl)-N-methylpyridi...
Many current technologies used in drug discovery and preclinical development programmes typically involve multi-step operations, extensive hands-on time, and lengthy liquid handling processe...
G Protein Coupled Receptors (GPCRs) are therapeutic targets for many medications used to treat a variety of disease states. A large number of genetic variants have been identified in the gen...